BR0316687A - Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos - Google Patents
Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivosInfo
- Publication number
- BR0316687A BR0316687A BR0316687-2A BR0316687A BR0316687A BR 0316687 A BR0316687 A BR 0316687A BR 0316687 A BR0316687 A BR 0316687A BR 0316687 A BR0316687 A BR 0316687A
- Authority
- BR
- Brazil
- Prior art keywords
- membrane vesicles
- adjuvant
- living organisms
- obtaining
- outer membrane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMPOSIçãO E ADJUVANTE VACINAL E MéTODO PARA A OBTENçãO DE ESTRUTURAS COCLEARES A PARTIR DE VESìCULAS DE MEMBRANA EXTERNA DE ORGANISMOS VIVOS". A presente invenção refere-se ao campo da imunologia, particularmente ao ramo referente aos adjuvantes e às vacinas. O objetivo técnico perseguido é o de obter estruturas cocleares a partir de vesículas de membrana externa (ampolas) de microorganismos, com o fim de empregá-las como adjuvantes ou como vacinas propriamente ditas. A invenção também se refere ao método de obtenção das estruturas cocleares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20020292A CU23313A1 (es) | 2002-11-27 | 2002-11-27 | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
PCT/CU2003/000016 WO2004047805A1 (es) | 2002-11-27 | 2003-11-27 | Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios. |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0316687A true BR0316687A (pt) | 2005-10-18 |
Family
ID=40122451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0316687-2A BR0316687A (pt) | 2002-11-27 | 2003-11-27 | Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060134134A1 (pt) |
EP (2) | EP2347764A3 (pt) |
CN (1) | CN1744883B (pt) |
AR (1) | AR042237A1 (pt) |
AT (1) | ATE530166T1 (pt) |
AU (1) | AU2003281911A1 (pt) |
BR (1) | BR0316687A (pt) |
CA (1) | CA2518906A1 (pt) |
CU (1) | CU23313A1 (pt) |
DK (1) | DK1602360T3 (pt) |
ES (1) | ES2376227T3 (pt) |
HK (1) | HK1088827A1 (pt) |
WO (1) | WO2004047805A1 (pt) |
ZA (1) | ZA200504729B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8642046B2 (en) * | 2007-10-09 | 2014-02-04 | Tufts University | Cholera vaccines |
CU20080215A7 (es) | 2008-11-19 | 2012-06-21 | Inst Finlay | Vacunas unitemporales |
WO2011027956A2 (ko) * | 2009-09-04 | 2011-03-10 | 주식회사이언메딕스 | 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델 |
CU20100083A7 (es) | 2010-05-05 | 2012-06-21 | Inst Finlay | Tolerogenos adyuvados como vacuna de malaria |
CU20110202A7 (es) | 2011-11-02 | 2013-12-27 | Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas | Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes |
EP2689775A1 (en) * | 2012-07-25 | 2014-01-29 | Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros | Cochleate with only one mamp |
WO2021031270A1 (zh) * | 2019-08-22 | 2021-02-25 | 四川大学 | 细菌膜囊泡及其分离制备系统和方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US597572A (en) * | 1898-01-18 | Indicator for oil-wells | ||
CH588887A5 (pt) | 1974-07-19 | 1977-06-15 | Battelle Memorial Institute | |
GB1578776A (en) | 1976-06-10 | 1980-11-12 | Univ Illinois | Hemoglobin liposome and method of making the same |
GB2026340B (en) | 1978-07-03 | 1982-12-22 | Ash P | Stabilising microvesicles |
DE2848965A1 (de) | 1978-11-11 | 1980-05-22 | Behringwerke Ag | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
US4271147A (en) | 1980-01-10 | 1981-06-02 | Behringwerke Aktiengesellschaft | Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same |
US4663161A (en) | 1985-04-22 | 1987-05-05 | Mannino Raphael J | Liposome methods and compositions |
RU2023448C1 (ru) | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
WO1993014744A1 (en) * | 1992-02-04 | 1993-08-05 | Chiron Corporation | Non-toxic lipid vaccine formulations |
US5994318A (en) * | 1993-10-04 | 1999-11-30 | Albany Medical College | Cochleate delivery vehicles |
US5643574A (en) | 1993-10-04 | 1997-07-01 | Albany Medical College | Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
US5851536A (en) | 1995-11-22 | 1998-12-22 | University Of Washington | Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
US5834015A (en) * | 1996-09-11 | 1998-11-10 | Albany Medical College | Protein-lipid vesicles and autogenous vaccine comprising the same |
US6180114B1 (en) | 1996-11-21 | 2001-01-30 | University Of Washington | Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
NO20002828D0 (no) * | 2000-06-02 | 2000-06-02 | Statens Inst For Folkehelse | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
GB0103170D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
-
2002
- 2002-11-27 CU CU20020292A patent/CU23313A1/es unknown
-
2003
- 2003-11-27 BR BR0316687-2A patent/BR0316687A/pt not_active IP Right Cessation
- 2003-11-27 DK DK03773445.6T patent/DK1602360T3/da active
- 2003-11-27 CN CN2003801092585A patent/CN1744883B/zh not_active Expired - Fee Related
- 2003-11-27 US US10/536,778 patent/US20060134134A1/en not_active Abandoned
- 2003-11-27 ES ES03773445T patent/ES2376227T3/es not_active Expired - Lifetime
- 2003-11-27 CA CA002518906A patent/CA2518906A1/en not_active Abandoned
- 2003-11-27 AU AU2003281911A patent/AU2003281911A1/en not_active Abandoned
- 2003-11-27 AT AT03773445T patent/ATE530166T1/de active
- 2003-11-27 WO PCT/CU2003/000016 patent/WO2004047805A1/es not_active Application Discontinuation
- 2003-11-27 EP EP10185705A patent/EP2347764A3/en not_active Ceased
- 2003-11-27 AR ARP030104387A patent/AR042237A1/es unknown
- 2003-11-27 EP EP03773445A patent/EP1602360B1/en not_active Expired - Lifetime
-
2005
- 2005-06-09 ZA ZA200504729A patent/ZA200504729B/en unknown
-
2006
- 2006-08-22 HK HK06109275.1A patent/HK1088827A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK1602360T3 (da) | 2012-02-13 |
ATE530166T1 (de) | 2011-11-15 |
EP2347764A3 (en) | 2011-10-26 |
ZA200504729B (en) | 2006-09-27 |
EP2347764A2 (en) | 2011-07-27 |
AR042237A1 (es) | 2005-06-15 |
AU2003281911A1 (en) | 2004-06-18 |
CA2518906A1 (en) | 2004-06-10 |
CN1744883A (zh) | 2006-03-08 |
CN1744883B (zh) | 2011-06-08 |
ES2376227T3 (es) | 2012-03-12 |
EP1602360B1 (en) | 2011-10-26 |
EP1602360A1 (en) | 2005-12-07 |
US20060134134A1 (en) | 2006-06-22 |
WO2004047805A1 (es) | 2004-06-10 |
HK1088827A1 (en) | 2006-11-17 |
CU23313A1 (es) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Plotkin et al. | A short history Section 1 vaccination | |
AR061333A1 (es) | Composiciones de vacuna de la neisseria | |
BR112012022688A2 (pt) | proteína de fusão, vesícula da membrana externa isolada, polinucleotídeo, composição farmacêutica, vacina, método para tratamento ou prevenção de infecção ou doença por neisseria, uso e método para fabricar uma proteína de fusão | |
BR112012022800A2 (pt) | composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica | |
BR0015961A (pt) | Antìgeno de neisseria de 85kda | |
EA200900076A1 (ru) | Применение определенных алкоксилатов спиртов в качестве адъюванта в области агротехники | |
WO2002009746A8 (en) | Vaccines comprising outer membrane vesciles from gram negative bacteria | |
BR0316687A (pt) | Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos | |
PH12019500108A1 (en) | Ultraportable system for intra-operative isolation and regulation of surgical site environments | |
CL2008003202A1 (es) | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. | |
PT1112747E (pt) | Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos | |
MX2010003220A (es) | Proteinas inmunogenicas de membrana exterior derivada de genoma de leptospira y composiciones y metodos basados en las mismas. | |
RU2014140731A (ru) | Варианты гемагглютинина и нейраминидазы гриппа | |
CL2023001142A1 (es) | Composiciones y métodos para la vacunación contra neisseria gonorrhoeae | |
ES2524468T3 (es) | Protección heteróloga contra pasteurella multocida proporcionada por células de P. multocida fur y sus extractos proteicos de membrana externa | |
Spooner et al. | A bacteriologic study of the influenza epidemic at Camp Devens, Mass. | |
NZ580603A (en) | Intradermal influenza vaccine | |
BR112023003571A2 (pt) | Vesículas de membrana externa | |
Martínez et al. | Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus | |
CU23377A1 (es) | Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes | |
MX2023000097A (es) | Adyuvantes de vacunas y metodos de sintetizacion y uso de estos. | |
RU2002122063A (ru) | Штам бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины | |
NAM et al. | Localized cutaneous infection due to Scedosporium apiospermum | |
PARK et al. | A case of cutaneous infection with Mycobacterium fortuitum | |
AR046937A1 (es) | Proteina nmb0928 y su uso en formulaciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |